From 2013 to 2023, New Zealand's per capita expenditure on contraceptives based on hormones or spermicides showed fluctuation. Notably, the market peaked in 2017 at $5.47, followed by a decline leading to 2023, where it stood at $4.74. The year-on-year changes reveal a decrease of approximately 1.25% from 2022 to 2023. Over the last five years, the Compound Annual Growth Rate (CAGR) indicates a slight negative trend.
Future trends to watch include the impact of emerging technologies in contraceptive methods, changing consumer preferences, and any shifts in government healthcare policies which might influence market demand and effectively alter consumer behavior in New Zealand.
